Trials have begun to determine the strength of immunity of the Oxford-AstraZeneca Covid vaccine on children aged between six and 17.
Report by Jonesia.
Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
